Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IMT-009 |
Trade Name | |
Synonyms | IMT 009|IMT009 |
Drug Descriptions |
IMT-009 is a monoclonal antibody targeting CD161, which potentially induces antitumor immune activity (Journal for ImmunoTherapy of Cancer 2022, Vol 10: Suppl 2). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IMT-009 | IMT-009 | 0 | 1 |